SAGE THERAPEUTICS INC (SAGE) Stock Balance Sheet
NASDAQ:SAGE - Nasdaq - US78667J1088 - Common Stock - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 45.22M | 81.02M | 70.99M | 162.70M | 294.20M | |||
| Marketable Securities | 378.63M | 423.40M | 682.19M | 1.11B | 1.45B | |||
| Receivables | 13.43M | 12.93M | 88.61M | 13.70M | 18.50M | |||
| Inventories | N/A | N/A | 1.50M | N/A | N/A | |||
| Other Current Assets | 17.19M | 13.95M | 26.06M | 50.80M | 39.80M | |||
| Total Current Assets | 454.48M | 531.30M | 869.35M | 1.34B | 1.80B | |||
| Non-Current Assets | ||||||||
| PPE Net | 11.13M | 11.64M | 6.38M | 13.40M | 19.10M | |||
| Other Non-Current Assets | 4.06M | 4.28M | 6.55M | 6.00M | 5.50M | |||
| Total Non-Current Assets | 15.19M | 15.92M | 12.93M | 19.40M | 24.70M | |||
| TOTAL ASSETS | 469.67M | 547.22M | 882.28M | 1.36B | 1.83B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 30.52M | 43.61M | 63.84M | 37.60M | 26.70M | |||
| Accounts Payable | 5.43M | 12.70M | 10.32M | 19.00M | 10.50M | |||
| Other Current Liabilities | 13.82M | 15.31M | 8.59M | 42.70M | 48.00M | |||
| Total Current Liabilities | 49.78M | 71.61M | 82.75M | 99.30M | 85.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 10.04M | 10.52M | 0.00 | 4.60M | 11.10M | |||
| Total Non-Current Liabilities | 10.04M | 10.52M | 0.00 | 4.60M | 11.10M | |||
| TOTAL LIABILITIES | 59.82M | 82.13M | 82.75M | 103.90M | 96.30M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -3.03B | -2.97B | -2.57B | -2.03B | -1.50B | |||
| Additional Paid In Capital | 3.44B | 3.44B | 3.37B | 3.29B | 3.23B | |||
| Common Shares | 6.00K | 6.00K | 6.00K | 0.00 | 0.00 | |||
| Treasury Stock | -400.00K | -400.00K | -400.00K | -400.00K | -400.00K | |||
| Other Shareholders' Equity | 142.00K | 244.00K | -814.00K | -10.20M | -2.70M | |||
| Shares Outstanding | 62.54M | 61.36M | 60.04M | 59.50M | 58.90M | |||
| Tangible Book Value per Share | 6.55 | 7.58 | 13.32 | 21.05 | 29.35 | |||
| Total Shareholders' Equity | 409.85M | 465.09M | 799.53M | 1.25B | 1.73B | |||
| TOTAL LIABILITIES AND EQUITY | 469.67M | 547.22M | 882.28M | 1.36B | 1.83B | |||
| Statistics | ||||||||
| Current Ratio | 9.13 | 7.42 | 10.51 | 13.46 | 21.13 | |||
| Return On Assets (ROA) | -75.46% | -73.22% | -61.37% | -39.28% | -25.09% | |||
| Return On Equity (ROE) | -86.47% | -86.15% | -67.73% | -42.54% | -26.48% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21